BBH 주가 전망 및 ETF 분석 - 배당·운용보수·보유종목·NAV·RSI·MACD

BBH

VanEck Biotech ETF

7월 28일 1:14 PM ET (한국 7/29 02:14)

$204.39

+0.82 ▲ +0.40%

BBH ETF is analyzed across 10 metrics including expense ratio, holdings, sector allocation, dividends, RSI, and MACD.

Total Expense Ratio

0.35%

Annual operating cost

Net Assets (AUM)

$396M

약 5430억원

Holdings

25 items

Dividend Yield

0.47%

Management Style

Passive

Category ⓘ	Global or ExUS Equities - Industry Sector	Asset Type ⓘ	Equities (Stocks)	Return% 1Y ⓘ	25.22%	Total Holdings ⓘ	25	Perf Week ⓘ	1.04%
ETF Type ⓘ	Global Equities	Active/Passive ⓘ	Passive	Return% 3Y ⓘ	8.66%	AUM ⓘ	$396M	Perf Month ⓘ	4.01%
Expense ⓘ	0.35%	NAV ⓘ	$203.61	Return% 5Y ⓘ	0.93%	52W High ⓘ	-3.84%	Perf Quarter ⓘ	10.08%
Dividend TTM ⓘ	$0.96 (0.47%)	Div Gr. 3/5Y ⓘ	8.47% 9.47%	Return% 10Y ⓘ	7.07%	52W Low ⓘ	30.64%	Perf Half Y ⓘ	3.27%
Flows% 1M ⓘ	-	Flows% YTD ⓘ	-1.81%	Return% SI ⓘ	13.15%	Volatility(W/M) ⓘ	1.23% 1.15%	Perf YTD ⓘ	7.99%
SMA20 ⓘ	-0.58%	SMA50 ⓘ	5.08%	SMA200 ⓘ	7.32%	RSI (14) ⓘ	56.09	Beta ⓘ	0.68
IPO ⓘ	2011/12/21	Prev Close ⓘ	$203.57	Perf Year ⓘ	23.89%	Avg Volume ⓘ	0.00M	Price ⓘ	$204.39

📊 VanEck Biotech ETF (BBH) Investment Analysis

ETF Overview

VanEck Biotech ETF · Global or ExUS Equities - Industry Sector

헬스케어 섹터 — 헬스케어 섹터 ETF (제약·바이오·의료기기)

2011년 상장, 15년 운영 중.

The VanEck Biotech ETF seeks to replicate, as closely as possible, the price and yield performance of the MVIS US Listed Biotech 25 Index, before fees and expenses. The ETF generally invests at least 80% of its total assets in the securities that make up its benchmark index. This biotech index includes common stocks and depositary receipts of biotech industry companies listed on U.S. exchanges. These companies may include mid-cap companies and foreign companies listed on U.S. exchanges. The ETF is a non-diversified fund.

📘 BBH ETF 자세히 알아보기 →

U.S.equitytechnologybiotechnology

규모: $396M 약 5430억원
운용사: VanEck
운용 방식: 패시브 (지수 추종)
상장일: 2011년

Cost Efficiency

Annual Expense Ratio · Category Rank · Long-Term Cost Impact

Low-cost ETF — 0.35% annually

상위 25% within Global or ExUS Equities - Industry Sector. For a ₩100M investment, roughly ₩350,000/year.

Effective Annual Expense Ratio (Net Expense Ratio)

상위 25%

0.35%

My positionTop 25%

Low range Average High range

Actual Cost Simulation by Investment Amount

$100.0M

Annual Expense Ratio

$350K

Save $230K per year vs. category average

Category Median Annual Cost

$580K

Based on expense ratio of 0.58%

10-Year Cumulative Expense Ratio (Long-term simulation assuming 7% annual market growth)

$6.3M

6.6% of returns you could have earned goes to the fund manager due to fees

💡 Because the expense ratio takes a slice of your assets every year, costs compound over 10 years and result in far greater losses than a simple sum (annual fee × 10). The 7% annual return assumption is based on the S&P 500's long-term average.

Defaults shown against $100K baseline portfolio. Adjust the slider to update the amount in real time.

Cheaper alternatives in the same category

HAUZ

Xtrackers International Real Estate ETF

0.10%

-0.25%p annually

VNQI

Vanguard Global ex-U.S. Real Estate ETF

0.12%

-0.23%p annually

PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

0.13%

-0.22%p annually

* A lower fee does not necessarily mean a better ETF. Consider the tracked index, liquidity, and tax treatment as well.

Long-Term Performance

1-year · 3-year · 5-year · 10-year returns · vs. benchmark · drawdown defense

Average long-term returns

Near the Global or ExUS Equities - Industry Sector median.+7.4%p vs. benchmark (SPY) over 1Y.

ℹ️ The "1Y·3Y·5Y·10Y" periods below represent annualized returns (CAGR) measured backward from today. Example: "3Y +12%" means the investment grew at a compounded 12% per year over the past three years.

If you had invested 10 year(s) ago

$100.0M

Today's value

$198.0M

→

Total gain

+$98.0M

Annualized +7.1%

1 Year

2025.07 ~ 2026.07

Annualized +25.22%

평균권

Outperformed the benchmark by 7.4%p annually

My positionMid-range

Low range Average High range

3 Years

2023.07 ~ 2026.07

Annualized +8.66% Cumulative +28.3%

평균권

Trailed the benchmark by 10.3%p annually

My positionMid-range

Low range Average High range

5 Years

2021.07 ~ 2026.07

Annualized +0.93% Cumulative +4.7%

평균권

Trailed the benchmark by 12.0%p annually

My positionMid-range

Low range Average High range

10Y

2016.07 ~ 2026.07

Annualized +7.07% Cumulative +98.0%

평균권

Trailed the benchmark by 7.8%p annually

My positionMid-range

Low range Average High range

10Y Cumulative Total Return Curve

2016-07-28 start, based on a 100M KRW base — read the curve values directly as units of 100M KRW (e.g., 308 → 3.08억 / 308M KRW). Both this ETF and the benchmark are rebased to 100 on the same start date for comparison.

BBH · Price Only BBH · Price + Cumulative Dividends BBH · Dividend Reinvested S&P 500 (SPY)

150

250

350

450

ℹ️ Price Only: Excludes dividends and tracks pure stock price only. Covered-call and high-dividend ETFs often show a flat or declining line on this view, which is meaningful from a "principal preservation" standpoint. Price + Cumulative Dividend: Share count stays the same and received dividends are accumulated as cash. Closely matches your actual account total assets. Reinvested: Dividends are immediately used to buy additional shares (adjClose-based, the industry standard for total return). The wider the gap between the three lines, the easier it is to gauge the effectiveness of the dividend strategy.

Annual Return Comparison

ETF returns vs S&P 500 (SPY) by calendar year

BBH S&P 500 (SPY)

+40%

−40%

+14%

2017

-13%

2018

+26%

2019

+22%

2020

+12%

2021

-14%

2022

+5%

2023

-7%

2024

+21%

2025

+7%

2026 YTD

ℹ️ Returns from January 1 to December 31 of each year. The current year (2026) column is dimmed to indicate YTD (incomplete). If blue is higher than gray, the ETF outperformed the benchmark in that year.

Win rate vs S&P 500 (SPY)

3 / 9Y

Lags behind benchmark (33%)

+ 2026 YTD: Behind (7.4% vs 8.5%)

2017 ✗

2018 ✗

2019 ✗

2020 ✓

2021 ✗

2022 ✓

2023 ✗

2024 ✗

2025 ✓

2026 ✗ YTD

ℹ️ Number of winning years versus S&P 500 (SPY) within a completed calendar year (1/1–12/31). The current year (YTD) is reported separately.

Downside Capture

🛡️ 76%

Falls less than the benchmark in drawdowns — strong downside protection

<85% (Defend) 85~110% (Track) >110% (Lag)

ℹ️ Average % drop of this ETF when S&P 500 (SPY) is −1%. Based on daily returns over the past 3 years (only days where the benchmark is negative).

Risk Profile

Volatility · Beta · Max Drawdown · Sharpe · Drawdown Recovery History

Overall Risk Grade

Low Risk

Less volatile than the market average, making it relatively easy to hold over time.

Beta (market sensitivity)

평균권

0.68

If the market rises +10% +6.8%

If the market falls -10% -6.8%

My positionMid-range

Low range Average High range

ℹ️ A beta of 1.0 moves in line with the market. Above 1 means it moves more than the market; below 1 means less.

Average daily range (last 1 month)

평균권

±1.15%

S&P 500 typically ±1.0~1.3% · Bond funds ±0.3% · Leveraged ETFs ±3% or more

Annual volatility trend (past 10 years)

ℹ️ This ETF's average daily price swing. 1% means "on average, moves about ±1% per day." The rolling curve below shows the annualized volatility (long-term standard measure) over time.

Max Drawdown · Past 10 years

-39.9%

Drawdown duration: 10 months

2021-08-09 → 2022-06-13

Still recovering

2015-07-31 Worst -35% 2026-07-01

ℹ️ Maximum drawdown is the largest peak-to-trough decline in the past. It represents the worst-case loss a long-term investor must psychologically endure.

Sharpe Ratio (Risk-Adjusted Return)

0.04

Weak — Low risk-adjusted returns

ℹ️ Annualized return minus the risk-free rate (3% annualized), divided by annualized volatility. A value above 1.0 is generally considered good risk-adjusted performance.

Estimated Monthly Maximum Loss (VaR 95%)

-9.8%

Historically, monthly losses exceeding this figure occurred only5%of the time.

ℹ️ A statistical estimate meaning "with 95% probability, monthly losses will not exceed this amount." The remaining 5% corresponds to crisis-level events such as financial crises or pandemics.

Dividend Analysis

Yield · Dividend history · After-tax income calculator

Pays dividends, but at a relatively low rate — 0.47% annually

Closer to a blend of growth and dividends.5-year dividend growth rate: +9.5%.

배당수익률

0.47%

주당 배당

$0.96

연간 기준

5년 성장률

9.5%

지급 주기

연배당

12월

📊 총 이력 2002~2025 (33건)

연도별 배당 총액 추이

주당 배당금을 연 단위로 합산한 금액입니다. 막대가 우상향이면 매년 배당이 늘어나고 있다는 뜻입니다.

$0.33 -3.0%

2016

$0.68 +108.9%

2017

$0.55 -19.3%

2018

$0.47 -14.3%

2019

$0.61 +28.8%

2020

$0.40 -34.7%

2021

$0.75 +88.7%

2022

$0.71 -4.8%

2023

$1.25 +75.6%

2024

$0.96 -23.6%

2025

$X.XX 그 해 총 배당금 +X% 전년 대비 증가 -X% 감소

최근 배당 이력 총 33건

아래로 스크롤하면 과거 배당 이력을 볼 수 있습니다.

배당락일

주당 금액

지급일

당시 수익률

2025-12-22

$0.957

—

1.15%

2024-12-23

$1.25

—

0.79%

2023-12-18

$0.713

—

0.91%

2022-12-19

$0.749

—

0.71%

2021-12-20

$0.397

—

0.53%

2020-12-21

$0.608

—

0.61%

2019-12-23

$0.472

—

0.33%

2018-12-20

$0.551

—

0.51%

2017-12-18

$0.683

—

0.80%

2016-12-19

$0.327

—

0.62%

2015-12-21

$0.337

—

0.27%

2013-12-23

$0.003

—

0.21%

2012-12-24

$0.184

—

0.34%

2011-11-15

$0.060

—

10.54%

2011-09-07

$0.002

—

11.04%

2011-08-16

$0.060

—

11.45%

2011-05-26

$0.107

—

10.28%

2011-04-26

$3.45

—

9.99%

2011-03-09

$0.007

—

0.02%

2009-10-30

$0.450

—

99.06%

2009-10-29

$0.460

—

96.27%

2009-09-09

$0.001

—

85.57%

2009-04-01

$27.86

—

100.52%

2009-03-11

$0.005

—

3.80%

2008-12-03

$1.09

—

3.94%

2008-05-21

$1.00

—

7.33%

2008-03-12

$0.004

—

5.08%

2007-06-27

$2.90

—

6.00%

2007-03-14

$0.004

—

5.18%

2007-02-05

$0.453

—

4.75%

2006-04-26

$2.56

—

4.49%

2002-07-17

$0.630

—

2.51%

2002-02-27

$0.003

—

0.01%

* "배당락일"은 배당받으려면 이 날 이전에 주식을 보유해야 하는 기준일입니다. 지급일·당시 수익률은 일부 종목에서 데이터가 없을 수 있습니다.

💰 내가 $100K 투자한다면

연간 배당금 (세후) $399

5년 누적 (세후) $2K

* 환율 1 가정, 배당소득세 15% 반영. 5년 누적은 배당 성장률 연 9.47% 가정.

* Qualified dividend middle-bracket approximation. Actual rate varies by total income.

Overall investment appeal

What this ETF fits best — strengths, weaknesses, and target investor profile

Strengths and weaknesses both present Check the fit below to see whether it matches your investing goal.

🎯 목적별 적합도

내가 이 ETF를 어떤 목적으로 활용할 수 있는지 확인하세요.

🌳

장기 보유

수년 이상 꾸준히 모아갈 때

보통

💵

배당 인컴

매월·분기 현금흐름이 목적일 때

부적합

⚡

단기 트레이딩

며칠~몇 주 단기 방향성 매매

매우 낮음

🧩

포트폴리오 보조

자산 배분·헤지 용도

낮음

👤

이런 분에게 어울려요

Long-term and recurring investors

✅ 강점

💸Low cost — 0.35% annually

⚠️ 약점·주의사항

🎯Trails benchmark by -12.0%p annually

Portfolio Composition

What's actually inside — sector weights and top holdings

25개 종목으로 구성

상위 섹터는 Healthcare (89%)

ℹ️ 왜 구성을 봐야 하나요?

ETF의 실제 성과는 담고 있는 종목과 섹터에서 나와요. 이름이 "S&P 500"이라도 기술주 비중이 유난히 높을 수 있고, "배당주 ETF"라도 몇몇 대형주에 쏠려 있을 수 있어요. 라벨보다 실제 구성을 확인하는 게 중요해요.

🔬 집중도 한눈에 보기

총 보유종목

25개

상위 10개 비중

70.8%

최대 단일 종목

14.63%

집중도(HHI)

733

보통

⚠️ 소수 종목·섹터에 집중되어 있어, 해당 종목/섹터가 흔들리면 ETF 전체가 크게 영향을 받아요.

🥧 섹터 비중

Healthcare

89.3%

📋 상위 보유 종목 Top 10 Top 10이 전체의 70.8% 차지

티커 옆의 점 색상 = 섹터 구분 (섹터 차트와 동일 색상)

#1 GILD Gilead Sciences Inc

14.63%

#2 AMGN Amgen Inc

14.54%

#3 VRTX Vertex Pharmaceuticals Inc

8.06%

#4 REGN Regeneron Pharmaceuticals Inc

7.51%

#5 ARGX Argenx SE

5.28%

INSM Insmed Inc

4.59%

#7 IQV IQVIA Holdings Inc

4.30%

#8 ALNY Alnylam Pharmaceuticals Inc

4.11%

#9 NTRA Natera Inc

3.98%

#10

UTHR United Therapeutics Corp

3.81%

Category Peers

Category: Global or ExUS Equities - Industry Sector

같은 카테고리 6종 중 AUM 1/6위 · 보수율 1/6위

카테고리: Global or ExUS Equities - Industry Sector

ℹ️ 왜 비교해야 하나요?

같은 카테고리 ETF끼리는 보수율·규모(AUM)·배당률을 비교해 볼 가치가 있어요. 보수율은 낮을수록 장기 수익에 유리하고, AUM이 크면 운용 안정성이 높아요. ▲ 표시는 BBH보다 유리, ▼ 표시는 BBH보다 불리를 뜻해요.

티커	ETF명	보수율	AUM	보유종목	배당률	YTD	1년
BBH	VanEck Biotech ETF	0.35%	$396M	25	0.47%	+7.99%	+23.89%
IDNA	iShares Genomics Immunology and Healthcare ETF	0.47% ▼	$189M ▼	63	0.87% ▲	-	+45.36% ▲
MEDI	Harbor Health Care ETF	0.8% ▼	$42M ▼	43	0.04% ▼	-	+20.31% ▼
GDOC	Goldman Sachs Future Health Care Equity ETF	0.75% ▼	$19M ▼	45	0.31% ▼	-	+15.45% ▼
MEDX	Horizon Kinetics Medical ETF	0.85% ▼	$18M ▼	33	1.15% ▲	-	+26.78% ▲
JDOC	JPMorgan Healthcare Leaders ETF	0.65% ▼	$9M ▼	64	0.83% ▲	-	+19.82% ▼

AUM 내림차순 정렬 · ▲ BBH보다 유리 · ▼ BBH보다 불리

Leveraged & Covered Call ETFs on the Same Theme

ETFs that approach the same theme with a different strategy

24 ETFs tracking the same theme as BBH using leveraged or covered call strategies (Leverage 8 · Inverse 8 · Covered Call 8)

Not direct derivatives of BBH, but ETFs that cover the same theme via a different strategy.

ℹ️ Which ETFs are included?

Among ETFs whose theme (category or sector) overlaps with BBH, some use special strategies. Leveraged ETFs aim for 2–3× the daily move, Inverse ETFs seek opposite-direction returns, and Covered Call ETFs generate monthly income from option premiums.

⚠️ Caution: Long-Term Holding

Leveraged and inverse ETFs track only the daily return. With high volatility, holding them for longer periods causes cumulative volatility decay—returns diverge further from the underlying index. They are meant for short-term trading.

📈 Leverage 8 ETFs that amplify the same theme by 2-3x (high volatility)